(Q38219638)
Statements
1 reference
Alemtuzumab: the advantages and challenges of a novel therapy in MS. (English)
1 reference
Hans-Peter Hartung
1 reference
Olaf Stüve
1 reference
Bernd C Kieseier
1 reference
Til Menge
1 reference
11 June 2014
1 reference
Identifiers
1 reference